|
|
|
Slonomics™ - Industrialized Gene Synthesis
Sloning BioTechnology GmbH
The synthesis of genetic constructs via the Slonomics™ technology utilizes various liquid handling, mixing, incubation and microplate handling procedures, performed via a multistep, convergent synthesis protocol. For the automated parallel production of such custom gene constructs, we developed a modular system architecture consisting of independently operating robotic stations.
|
Synthetic Life - Ethics for a New Biology
Universitat Autònoma de Barcelona and DNA2.0
Synthetic biology allows for the direct chemical synthesis of any gene, operon and chromosome. Not only does synthetic biology facilitate copying and editing existing genetic information, it also instantly permits the creation of any imaginable completely novel genetic information without being constrained by nature.
|
|
|
|
|
|
Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain
|
|
|
BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK
|
|
|
Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada
|
|
|
Production Chemist II
Independent
Torrance, CA, USA
|
|
|
Research Chemist
Independent
Torrance, CA, USA
|
|
|
phD Scholarship in BioInformatics
Universitat Rovira i Virgili
Tarragona, Spain
|
|
|
QC Analyst
Genomic Health
Redwood City, CA, USA
|
|
|
|
SBMC 08 Conference on Systems Biology of Mammalian Cells, Dresden, Germany
22 May 2008 - 24 May 2008
SBMC 2008 will present cuttingedge experimental, theoretical and computational approaches to unravel the design principles underlying a wide range of regulatory processes in mammalian cells, including cell organization, metabolic pathways, genetic and signaling networks, tissue morphogenesis and development, and pathogenetic mechanisms.
|
2008 International Conference on BioMedical Engineering and Informatics (BMEI 2008), Hainan, China
27 May 2008 - 30 May 2008
The aim of BMEI2008 is to bring together researchers working in many different areas of biomedical engineering and informatics to foster international collaborations and exchange of new ideas.
|
|
| |
|
|
|
|
A global abstract analysis of selected histone-modifying enzymes using AKS
Active Motif
A global abstract analysis (GAA) was performed on twelve histone-modifying enzymes (ASH1, CARM1, CBP, CKII, EZH2, MSK1, MST1, NSD1, PCAF, RIZ1, SIRT2 and TIP60) to demonstrate how this approach can help uncover biological relationships, scientific information, and overall publication trends from PubMed abstracts and related biological databases. This GAA study showed that published research of histone-modifying enzymes has increased significantly since 2001 and that many reported studies have fo
|
|
|
|
|
Tissue Engineering & Stem Cell Technology Report 2007
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.
|
|
|